Nutex Health Inc. (NASDAQ:NUTX – Get Free Report)’s share price gapped down before the market opened on Friday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $105.34, but opened at $89.05. Nutex Health shares last traded at $87.46, with a volume of 229,541 shares changing hands.
The company reported $1.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The business had revenue of $151.68 million during the quarter, compared to analysts’ expectations of $258.82 million.
Wall Street Analyst Weigh In
Several brokerages have recently commented on NUTX. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.
Institutional Trading of Nutex Health
Hedge funds have recently bought and sold shares of the company. Pertento Partners LLP purchased a new stake in Nutex Health in the third quarter worth approximately $27,940,000. Topline Capital Management LLC boosted its stake in shares of Nutex Health by 80.0% in the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock valued at $57,505,000 after purchasing an additional 247,436 shares in the last quarter. Marshall Wace LLP grew its holdings in shares of Nutex Health by 333.4% during the 2nd quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock valued at $11,770,000 after purchasing an additional 72,734 shares during the last quarter. Millennium Management LLC raised its position in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after purchasing an additional 61,308 shares during the period. Finally, Divisadero Street Capital Management LP bought a new stake in Nutex Health in the second quarter worth $7,481,000. Institutional investors own 5.32% of the company’s stock.
Nutex Health Trading Down 17.5%
The firm’s 50-day simple moving average is $138.40 and its 200-day simple moving average is $124.53. The company has a quick ratio of 3.18, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $614.45 million, a PE ratio of 4.70 and a beta of 0.03.
Nutex Health Company Profile
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Featured Articles
- Five stocks we like better than Nutex Health
- Buy this Gold Stock Before May 15th, 2026
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- J.P. Morgan is betting on this coin
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
